FIRMAXOL, created in 2015 (Belgium), from 303 sister brands and 4958 competing brands. The FIRMAXOL brand is owned by Perrigo, a company listed in New York. Its International Securities Identification Number (ISIN) is IE00BGH1M568. FIRMAXOL belongs to the Drug Manufacturers business sector.